BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9816354)

  • 1. Relation between depression and circulating immune products in patients with advanced colorectal cancer.
    Allen-Mersh TG; Glover C; Fordy C; Henderson DC; Davies M
    J R Soc Med; 1998 Aug; 91(8):408-13. PubMed ID: 9816354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer.
    Huang A; Fuchs D; Widner B; Glover C; Henderson DC; Allen-Mersh TG
    Br J Cancer; 2002 Jun; 86(11):1691-6. PubMed ID: 12087451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases.
    Earlam S; Glover C; Fordy C; Burke D; Allen-Mersh TG
    J Clin Oncol; 1996 Jan; 14(1):171-5. PubMed ID: 8558193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer.
    Rich T; Innominato PF; Boerner J; Mormont MC; Iacobelli S; Baron B; Jasmin C; Lévi F
    Clin Cancer Res; 2005 Mar; 11(5):1757-64. PubMed ID: 15755997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of interleukin-2 receptor alpha in the serum of colorectal cancer patients is unlikely to result only from T cell up-regulation.
    Huang A; Quinn H; Glover C; Henderson DC; Allen-Mersh TG
    Cancer Immunol Immunother; 2002 Mar; 51(1):53-7. PubMed ID: 11845260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of regional and systemic fluorinated pyrimidine chemotherapy on quality of life in colorectal liver metastasis patients.
    Earlam S; Glover C; Davies M; Fordy C; Allen-Mersh TG
    J Clin Oncol; 1997 May; 15(5):2022-9. PubMed ID: 9164214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of serum cytokines in patients with congestive heart failure.
    Orús J; Roig E; Perez-Villa F; Paré C; Azqueta M; Filella X; Heras M; Sanz G
    J Heart Lung Transplant; 2000 May; 19(5):419-25. PubMed ID: 10808148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological variation of interleukin 6 (IL-6) and soluble interleukin 2 receptor (sIL2R) in serum of healthy individuals.
    Cava F; González C; Pascual MJ; Navajo JA; González-Buitrago JM
    Cytokine; 2000 Sep; 12(9):1423-5. PubMed ID: 10976007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune activation markers to predict AIDS and survival in HIV-1 seropositives.
    Fuchs D; Jäger H; Popescu M; Reibnegger G; Werner ER; Dierich MP; Kaboth W; Tilz GP; Wachter H
    Immunol Lett; 1990 Oct; 26(1):75-9. PubMed ID: 2125976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor.
    Kaminska J; Kowalska M; Kotowicz B; Fuksiewicz M; Glogowski M; Wojcik E; Chechlinska M; Steffen J
    Oncology; 2006; 70(2):115-25. PubMed ID: 16645324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of sIL2R, sCD23, sICAM-1, IL6 and sCD 14 serum levels in B-cell chronic lymphocytic leukemia.
    Callea V; Morabito F; Luise F; Piromalli A; Filangeri M; Stelitano C; Iacopino P; Nobile F; Brugiatelli M
    Haematologica; 1996; 81(4):310-5. PubMed ID: 8870374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).
    Deswal A; Petersen NJ; Feldman AM; Young JB; White BG; Mann DL
    Circulation; 2001 Apr; 103(16):2055-9. PubMed ID: 11319194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of diet, tumour volume and patient-related factors to weight loss in patients with colorectal liver metastases.
    Fordy C; Glover C; Henderson DC; Summerbell C; Wharton R; Allen-Mersh TG
    Br J Surg; 1999 May; 86(5):639-44. PubMed ID: 10361185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Aukrust P; Ueland T; Lien E; Bendtzen K; Müller F; Andreassen AK; Nordøy I; Aass H; Espevik T; Simonsen S; Frøland SS; Gullestad L
    Am J Cardiol; 1999 Feb; 83(3):376-82. PubMed ID: 10072227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble interleukin 2 receptor (sIL2R) in monitoring advanced lung cancer during chemotherapy.
    Brunetti G; Bossi A; Baiardi P; Jedrychowska I; Pozzi U; Bacchella L; Bernardo G
    Lung Cancer; 1999 Jan; 23(1):1-9. PubMed ID: 10100141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
    Tang S; Xiao H; Fan Y; Wu F; Zhang Z; Li H; Yang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):325-9. PubMed ID: 12126553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of inflammatory cytokines in the progression of colorectal cancer.
    Chung YC; Chang YF
    Hepatogastroenterology; 2003; 50(54):1910-3. PubMed ID: 14696431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes.
    Wadwa RP; Kinney GL; Ogden L; Snell-Bergeon JK; Maahs DM; Cornell E; Tracy RP; Rewers M
    Int J Biochem Cell Biol; 2006; 38(5-6):996-1003. PubMed ID: 16271309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha.
    Hofmann B; Bass H; Nishanian P; Faisal M; Figlin RA; Sarna GP; Fahey JL
    Clin Exp Immunol; 1992 Jun; 88(3):548-54. PubMed ID: 1606739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vesnarinone on peripheral circulating levels of cytokines and cytokine receptors in patients with heart failure: a report from the Vesnarinone Trial.
    Deswal A; Petersen NJ; Feldman AM; White BG; Mann DL
    Chest; 2001 Aug; 120(2):453-9. PubMed ID: 11502643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.